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Introduction  
 
Construct and property of cartilage 
 
Hyaline cartilage is the most widespread cartilage in the human body. In diarthroidal 
joints hyaline cartilage covers the contact zones of two interlocked bones and is called 
articular cartilage.[1] Articular cartilage is a unique type of well-characterized connective 
tissue. It has the lowest cellular volume of any tissue in the human body. In humans, 
chondrocytes contribute only about 1% of the tissue volume. The remaining 99% is made 
up of a complex ECM. The chondrocytes themselves synthesize all necessary ECM 
components. The ECM is composed of collagen and Proteoglycans. [1] 
Collagen is the primary constituent of the ECM of articular cartilage. 90-95% of the 
collagen is collagen II which is often used as a marker for chondrogenic differentiation. 
The collagen II fibrils are responsible for the tensile strength of the tissue.[2] Aggrecan is 
the most common proteoglycan in articular cartilage, and it is responsible for the 
compressive strength of the tissue.[1] Thus, the expressions of GAGs and Aggrecan are 
also used as specific markers for chondrogenic differentiation.  
 
Repair of cartilage injury 
 
Articular cartilage is avascular, aneural, and alymphatic tissue. Therefore, the intrinsic 
ability of articular cartilage to repair itself is limited. Due to the poor ability of articular 
cartilage to heal itself, and the limited clinical treatment options, tissue engineering may 
provide the most promising approach to articular cartilage regeneration. The matrix 
assisted autologous chondrocytes transplantation (MACI), which follows the tissue 
engineering approach, is the current state of the art treatment option.[3] 
For this treatment, cartilage cells are taken from the patient, expanded in vitro and then 
seeded onto a scaffold (the matrix). This scaffold will then be implanted into the cartilage 
defect, replacing the damaged cartilage respectively the lost cartilage tissue. 
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Unfortunately a major obstacle in applying this method is the limited number of native 
cartilage cells, the so called chondrocytes, from the patient. This fact makes it necessary 
to expand the limited number of cartilage cells. A principal of cartilage tissue engineering 
is the application of mechanical stimulation to simulate in vivo condition and enhance 
chondrocyte metabolic activity and ECM production.[2]It is well studied that HP is the 
most important mechanical loading in cartilage regeneration. HP provides a robust 
method for chondrocyte stimulation, as it can be applied to chondrocytes in monolayer [4] 
, 3-D constructs [5], as well as explants [6]. 
 
Hydrostatic pressure bioreactors 
 
Bioreactors are widely used for cartilage tissue engineering. In general, there are two 
methods of applying HP, and they both showed advantages and disadvantages. In the first 
method, HP is applied by compressing a gas phase that transmits load through the 
medium to the cells. Those systems use a strong pressure chamber, therefore, could 
provide high pressure of up to 50 MPs.[7, 8] However, this method may alter the gas 
concentration within the culture medium. Alternatively, a less complicated approach 
involves applying HP by compressing only the fluid phase, which limits any changes in 
gas solubility within the chamber.[9, 10] This method generally involves connecting a 
fluid-filled chamber by hose to a piston attached directly to a hydraulic press, controlled 
by a computer. On the contrary to the first method, this type of bioreactor often uses a 
relatively fragile construct that can only resist low pressure. Both types of bioreactors also 
include temperature control, generally by placing the chamber in a water bath. Finally, 
either type of bioreactor may be altered to allow for semicontinuous medium perfusion. 
This alternation can avoid frequent medium changes, and reduce the risk of 
contamination. However, such additions will make the bioreactor more complex. While a 
separate perfusion system is inevitable for method two, it is possible to generate various 
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pressure protocols by controlling two electromagnetic valves of the in-and outflow of 
medium. However, due to the restrict relationship of flow rate, volume of the chamber 
and frequency, bioreactors of the second type still needs to add a separate perfusion 
system and can only apply to 3-D constructs. Thus, it is necessary to establish a novel 
bioreactor for HP loading that not only simultaneously permits medium perfusion but also 
has a less complex design.  
 
Hydrostatic pressure and perfusion 
 
HP has been extensively used for increasing the metabolic activity of chondrocytes in 
tissue engineering studies. The effects of HP on chondrocytes cultured in monolayer, 3-D 
constructs, as well as cartilage explants. In studies involving HP application, there are 
large amount of variations of the magnitude, frequency, and duration of HP. It was 
shown, that a window of effective loads and frequencies exist between 0.1 and 15 MPa 
and 0.05 and 1 Hz, respectively that produce positive results when culturing 
chondrocytes.[11, 12] The duration varies from 4 days to 8 weeks. With appropriate 
parameters, HP appears to be a promising method of stimulating chondrogenic 
differentiations. However, it should be noted that chondrocytes in monolayer respond 
differently to HP than 3-D constructs because of the absence of abundant ECM.[12] 
Additionally, despite the large number of studies involving hydrostatic pressure, most of 
the studies used animal cells. Animal cells have been shown to have a different response 
to HP stimulation than human chondrocytes.[13] 
Perfusion supplies nutrition and removes waste from the culture. Is also affects the 
chondrogenic activity.[14, 15] However, the effects of perfusion can be highly dependent 
on the medium flow-rate and the type of object. Numerous bioreactor systems involving 
HP also include a perfusion system. Nevertheless, all the studies neglected the effect of 
perfusion in addition to HP. Thus, the question remains what role did perfusion and HP 
play respectively in stimulating chondrogenic differentiation? 
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Objective of the study 
     
Motivated by the problems mentioned above, it is hypothesized that 1) a novel bioreactor 
for dynamic hydrostatic pressure loading that simultaneously permits medium perfusion 
with a simple construct can be established for chondrocyte cultures; and 2) both HPP and  
P can effect differentiation and metabolism of human chondrocytes, whereas, the effect of 
HP and P addresses different aspects. To test the hypotheses, two studies were carried out 
and demonstrated in publication 1 and publication 2 respectively.   
Publication 1 described the mechanical design and properties of the bioreactor. It consists 
of a medium reservoir, a pump that pressurizes the medium to create pressure, a pressure 
reservoir, an inlet valve, the test chamber including a temperature sensor and a pressure 
sensor, an outlet valve and a medium reservoir which are all connected by flexible tubes. 
The medium reservoir provides a hole covered with a filter for gas exchange. The test 
chamber provided space for one well-plate, with could meet requirements of various 
studies. The bioreactor was controlled via a purpose-built real-time LabVIEW software 
program which controls the pump, the valves and the pressure sensor self-sustaining. 
Frequency, pressure and the duration in hours per day can be adjusted by the user to set 
up the pressure mode of the bioreactor. The pressure could be achieved up to 270 kPa, 
and frequency up to 0.1 Hz which is within the range of 0.1~15MPa and 0.05~1Hz of  
benefit chondrogenic differentiation. Additionally, a cell test with human articular 
chondrocytes was performed. Chondrocytes were put in the bioreactor for four days with 
pressure of 100 kPa and a frequency of 0.01 Hz for 24 h/day before WST-1 assay to 
measure the proliferation of the cells. The results showed that cell viability was not 
decreased by the bioreactor. In this study a novel bioreactor for simultaneous dynamic 
hydrostatic pressure and perfusion was successfully introduced. A purpose-built program 
was developed to control the pump and valves, which reduced the complexity of the 
construct. This study showed the bioreactor has extensive prospects in cartilage tissue 
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engineering studies.  
In this study, as a co-author, I helped to modify the bioreactor and the software and 
optimized the parameters of the loading. I performed the cell viability test and provided 
the results. Finally, I took part in writing the manuscript. 
 
Publication 2 addresses hypothesis 2) by comparing effects of HPP and P for 
differentiation and dedifferentiation of human chondrocytes. In order to approach clinical 
applications, human chondrocytes are used in this study. The cells were cultured in 37oC, 
5% CO2 until passage 2 before divided in to 3 groups: HPP, P and C. For P and HPP, 
perfusion was applied with a medium flow rate of 2 ml/min for 20 h/day for 4 days. HPP, 
hydrostatic pressure of 0.1 MPa for 2 h (loading), followed by2 h rest (off-loading), was 
applied each day. Cells of group C were kept in static cultures. The bioreactor system 
introduced in publication 1 was utilized in this study. The chondrocytes were evaluated 
with real-time PCR for COL2A1, COL1A1, ACAN and MMP 13. More importantly, a 
full gene expression profile was displayed via RNA-sequencing. This study compared for 
the first time the effects of HP and P. Also, it is the first whole gene expression profile of 
human chondrocytes after either stimulation that has been published. Under those 
circumstances, not only the well-known cartilage genes like COL2A1, ACAN and SOX9 
but also genes which have not been commonly tested in bioreactors such as CYTL1 and 
GDF5 were examined. In addition, the state of art RNA-sequencing provided changes of 
gene expression influenced by HPP and P. Thereby, the study provides new insight into 
how HP and P enhance cartilage differentiation and inhibit catabolic effects. 
As a first author, I designed and performed the experiment except for the RNA-
sequencing while Dr. Susanne Mayer-Wagner introduced the RNA-sequencing technique, 
which was an important part of this study. Apart from this, Dr. Susanne Mayer-Wagner 
provided a lot of advises though out the whole study. Last but not least, both authors 
wrote the manuscript together. In this case, both authors contributed equally to this study. 
Hence, a shared-authorship came to be.   
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ACAN aggrecan 
COL1A1 collagen type 1 α1 chain 
COL2A1 collagen type 2 α1 chain 
CYTL1 cytokine like 1 
ECM extracellular matrix 
GAGs glycosaminoglycans 
GDF5 growth differentiation factor 5  
HP hydrostatic pressure 
HPP hydrostatic pressure and perfusion 
MACI 
matrix assisted autologous chondrocytes 
transplantation 
MMP 13 matrix-metalloproteinase 13 
P perfusion 
RNA ribonucleic acid  
SOX9  SRY (sex determining region Y)-box 9 
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Summary 
 
Articular cartilage has poor self-repairing capacity. Hence tissue engineering is regarded 
as a promising approach for cartilage regeneration. Hydrostatic pressure (HP) and/or 
perfusion (P) have been widely used in tissue engineering studies to increase the 
chondrogenic activity of chondrocytes. The objective of this study was to establish a 
hydrostatic pressure bioreactor which permits perfusion and in a second step, to 
investigate the effect of HP and P on human chondrocytes. 
There were various types of bioreactors used in previous studies, although only a few 
included a perfusion system. The absence of a perfusion system causes frequent manual 
intervention but bioreactors with perfusion systems were considered to be too complex. 
Therefore, a simple design for a bioreactor which allows applying HP and P was 
necessary for further studies. For HP studies involving a perfusion system, the effect of 
perfusion has been neglected. When applied simultaneously the individual effect of HP 
and P was still unknown. In this study, a novel bioreactor was established. With this 
system, HPP and P were applied on human chondrocytes respectively. Complete gene 
profile was generated by RNA-sequencing.   
The bioreactor was validated by finite element model, computational fluid dynamics and 
cell proliferation test. The results showed that the bioreactor could provide dynamic HP 
of 0.1 Mpa, 0.001-0.1 Hz by controlling the valves and pump by a computer. 
Furthermore, the bioreactor and stimuli did not affect proliferation of the chondrocytes.  
HPP and P were applied on human chondrocytes utilizing the bioreactor system 
mentioned above. A complete gene profile was generated by RNA-sequencing. Highly 
relevant biomarkers such as COL2A1, COL1A1, ACAN and MMP 13 were examined by 
real-time PCR. Both treatments showed a large variation to the control group, but a 
relatively high similarity between the treatments (P and HPP). HPP and P increased 
COL2A1 expression and decreased COL1A1, Both treatments were also able to inhibit 
catabolic effects. HPP and P decreased the expression of MMP-3, MMP-13 and 
ADAMTS4. HPP treatment maintained ACAN expression while P decreased it. When 
compared with P, HPP also increased expression of ITGA10 and TNC which are involved 
chondrocyte adhesiveness. 
Taken together, both HPP and P benefit cartilaginous cells but hydrostatic pressure was 
needed in addition to perfusion to evoke the full beneficial effects on chondrocytes. As 
the effects gained by adding hydrostatic pressure were not significantly superior to effects 
obtained by pure perfusion, the parameters of hydrostatic pressure might require further 
optimization. Our findings furthermore demonstrated that sequencing can be a useful tool 
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in exploring interrelationships in bioreactor studies. The simplified bioreactor could be a 
financially rewarding alternative to conventional bioreactor systems and be suitable for 
clinical use in expanding chondrocytes for cartilage repair without causing 
dedifferentiation of the expanded cartilage cells. This would resolve a mayor problem of 
current autologous chondrocyte transplantation (ACT) treatments. 
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Zusammenfassung 
 
Gelenkknorpel besitzt ein ungenügendes Selbstheilungsvermögen. Daher werden 
Methoden des Tissue Engineerings als vielversprechender Heilungsansatz gesehen.  
Dabei wird hydrostatischer Druck (HP) und/oder Perfusion (P) häufig in Tissue 
Engineering Studien eingesetzt, um die chondrogene Aktivität von Chondrozyten zu 
erhöhen.  
Das Ziel dieser Studie war es einen neuartigen Hydrostatikdruck-Bioreaktor zu etablieren, 
der zusätzlich die Perfusion der Zellen zulässt um in einem zweiten Schritt den Effekt von 
sowohl hydrostatischem Druck als auch der Perfusion bzw. deren Kombination zu 
untersuchen. 
Es wurden verschiedenste Bioreaktoren in bisherigen Studien eingesetzt, allerdings nur 
eine kleine Anzahl besitzen zusätzlich eine Perfusionssystem. Das Fehlen eines 
Perfusionssystems erfordert häufiges, manuelles eingreifen. Dies ist aufwändig und 
erhöht die Gefahr von Kontaminierung und Anwendungsfehlern. Jedoch wurden 
Bioreaktoren mit Perfusionssystemen als zu Komplex angesehen. Daher war es 
notwendig, einen einfach designten Bioreaktor zu entwickeln, welcher sowohl die 
Belastung mit hydrostatischem Druck als auch einen Perfusion zulässt. Außerdem wurde 
bisher in Studien mit hydrostatischem Druck und einem Perfusionssystem der Einfluss 
der Perfusion vernachlässigt. Daher gab es keine Angaben zum Einfluss der Perfusion. In 
den hier beschriebenen Studien wurde aus diesen Gründen ein neuartiger Bioreaktor 
konstruiert. Mit diesem System wurde dann der Einfluss von HP bzw. P auf 
Knorpelzellen untersucht und unter anderem umfangreiches Genprofil der so stimulierten 
Knorpelzellen mit Hilfe von RNA-Sequenzing erstellt. Zuerst wurde der Bioreaktor 
wurde über ein Finite Elemente Model und eine numerische Stömungsberechnung 
charakterisiert sowie ein Proliferationstest (WST-1 – Test) durchgeführt. Die Ergebnisse 
zeigen, dass der Bioreaktor mit einem dynamischen hydrostatischen Druck von 0,1 Mpa 
bei einer Frequenz von 0,001-0,1 Hz betrieben werden kann, wobei die Ventile und die 
Pumpe von einem Computer gesteuert werden. Dies hatte auserdem keinen negativen 
Einfluss auf die Proliferation der im Bioreaktor kultivierten Chondrozyten. HPP und P 
wurden in einem zweiten Experiment auf humanen Knorpelzellen appliziert. Danach 
wurde ein umfangreiches Genprofil mittels RNA-Sequencing erstellt. Hochrelevante 
Biomarker wie Collagen2A1, Collagen1A1, Agrecan, und MMP 13 wurden mit Hilfe von 
real-time PCR untersucht. Beide Stimuli zeigten große Unterschiede zur Kontroll-Gruppe 
aber keine großen Unterschiede zwischen den Stimuli P und HPP. Beide Stimuli hatten 
eine Erhöhung der COL2A1 und eine Erniedrigung der COL 1A1 Expression zur Folge. 
35 
 
 
Damit unterdrückten beide Stimuli einen katabolen Effekt. HPP und P verminderten 
weiterhin die Expression von MMP-3, MMP-13 und ADAMTS4. HPP wirkte erhaltend 
auf die ACAN Expression während nach Perfusion allein diese vermindert war. Im 
Vergleich zu P war bei HPP die Expression von ITGA10 und TNC, beides beteiligt an der 
Chondrozyten Adhäsion, erhöht. 
Zusammengefasst hat sowohl HPP als auch P einen positiven Effekt auf den Erhalt der 
chondrogenen Eigenschaften von kultivierten Chondrozyten wobei der Effekt der 
Kombination von hydrostatischem Druck und Perfusion einen zusätzlichen Vorteil 
gegenüber der Perfusion zeigte. Allerdings konnte in dieser Studie mit den untersuchten 
Parametern keine signifikanten Unterschiede gezeigt werden. Daher sollte der Parameter 
Hydrostatischer Druck in nachfolgenden Untersuchungen weiter optimiert werden. 
Unsere Ergebnisse zeigen weiterhin, dass das Erstellen eines Genprofils mittels RNA-
Sequencing ein nützliches Instrument bei der Untersuchung der Zusammenhänge der 
Parameter bei Untersuchen von Bioreaktor-Studien sein kann. Außerdem zeigt diese 
Studie, dass ein Bioreaktor mit vereinfachtem Design eine attraktive Alternative 
gegenüber konventionellen Bioreaktoren oder Kultivierungsmethoden sein kann, um als 
klinische Methode zur Expansion von Chondrocyten zur autologen Chondrozyten 
Transplantation (ACT) eingesetzt zu werden, ohne dass die expandierten Zellen Ihre 
chondrogenen Eigenschaften verlieren. Dies würde ein signifikantes Problem der 
gegenwärtig angewandten  ACT lösen. 
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